Keros Therapeutics, Inc. (KROS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.87
Day's range
$11.56

Keros Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 2.41 M $26.63 M   5.29% 6.48%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 1.36 M $15.02 M   277.45% 3.66%
05/15/2026 831.42 K $9.18 M   100.00% 2.23%
ORBIMED ADVISORS LLC 05/15/2026 759.16 K $8.38 M   -5.60% 2.04%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 724.93 K $8.00 M   -7.53% 1.95%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 706.07 K $7.80 M   -8.11% 1.90%
FEDERATED HERMES, INC. 05/11/2026 689.23 K $7.61 M   5.27% 1.85%
05/08/2026 682.04 K $7.53 M   100.00% 1.83%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 681.46 K $7.52 M   7.28% 1.83%
MADISON AVENUE PARTNERS, LP 05/15/2026 626.58 K $6.92 M   -23.93% 1.68%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 590.25 K $6.52 M   -55.77% 1.59%
STATE STREET CORP 05/15/2026 561.73 K $6.20 M   -47.79% 1.51%
D. E. SHAW & CO., INC. 05/15/2026 509.61 K $5.63 M   -32.54% 1.37%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 453.48 K $5.01 M   -23.36% 1.22%
CITADEL ADVISORS LLC 05/15/2026 406.67 K $4.49 M   -13.94% 1.09%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 406.56 K $4.49 M   125.19% 1.09%
TWO SIGMA INVESTMENTS, LP 05/15/2026 363.84 K $4.02 M   14.26% 0.98%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 321.36 K $3.55 M   453.94% 0.86%
NUVEEN, LLC 04/30/2026 262.08 K $2.89 M   315.35% 0.70%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 257.88 K $2.85 M   -19.75% 0.69%
NORTHERN TRUST CORP 05/14/2026 254.19 K $2.81 M   1.44% 0.68%
MAN GROUP PLC 05/15/2026 238.62 K $2.63 M   25.45% 0.64%
GOLDMAN SACHS GROUP INC 05/15/2026 224.48 K $2.48 M   -61.99% 0.60%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 195.02 K $2.15 M   224.61% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 179.95 K $1.99 M   -3.66% 0.48%
LOS ANGELES CAPITAL MANAGEMENT LLC 05/08/2026 172.20 K $1.90 M   409.89% 0.46%
Y-INTERCEPT (HONG KONG) LTD 04/27/2026 164.48 K $1.82 M   40.15% 0.44%
MACKENZIE FINANCIAL CORP 05/13/2026 152.45 K $1.68 M   196.68% 0.41%
WELLS FARGO & COMPANY/MN 05/11/2026 151.04 K $1.67 M   361.02% 0.41%
UBS GROUP AG 05/05/2026 145.57 K $1.61 M   49.95% 0.39%
EMPOWERED FUNDS, LLC 06/16/2026 145.52 K $1.61 M   142.21% 0.39%
BESSEMER GROUP INC 05/06/2026 143.85 K $1.59 M   0.00% 0.39%
CITADEL ADVISORS LLC 05/15/2026 129.90 K $1.43 M   -36.14% 0.35%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 127.30 K $1.41 M   100.00% 0.34%
MORGAN STANLEY 05/15/2026 124.11 K $1.37 M   -46.15% 0.33%
BANK OF NEW YORK MELLON CORP 05/05/2026 120.94 K $1.34 M   -0.52% 0.32%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 109.02 K $1.20 M   180.62% 0.29%
MILLENNIUM MANAGEMENT LLC 05/15/2026 106.86 K $1.18 M   -51.47% 0.29%
AMERIPRISE FINANCIAL INC 05/15/2026 102.48 K $1.13 M   -16.57% 0.28%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 97.32 K $1.07 M   416.25% 0.26%
XTX TOPCO LTD 05/15/2026 88.32 K $975.08 K   747.29% 0.24%
INVESCO LTD. 05/12/2026 87.77 K $969.00 K   0.39% 0.24%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 81.31 K $897.68 K   0.66% 0.22%
HRT FINANCIAL LP 05/14/2026 77.00 K $850.00 K   -70.49% 0.21%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 65.44 K $721.00 K   100.00% 0.18%
AMERICAN CENTURY COMPANIES INC 05/15/2026 64.26 K $709.43 K   75.38% 0.17%
RBF CAPITAL, LLC 05/18/2026 62.80 K $693.31 K   -23.16% 0.17%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 59.59 K $657.92 K   100.00% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 59.40 K $655.78 K   -66.21% 0.16%
RANGELEY CAPITAL, LLC 05/15/2026 54.40 K $600.58 K   -43.80% 0.15%

Keros Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 205 institutional investors and hedge funds held shares of Keros Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 2.41 M

Nantahala Capital Management, LLC: 1.36 M

ORBIMED ADVISORS LLC: 759,155

Qube Research & Technologies Ltd: 724,926

JACOBS LEVY EQUITY MANAGEMENT, INC: 706,071

FEDERATED HERMES, INC.: 689,229

49.96% of Keros Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 22.15 M shares in the last 24 months. This purchase volume represents approximately $251.42 M in transactions.